Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

Dr Pavan Bhargava shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights into how new ...

Fatty fish have previously been linked with lower levels of multiple sclerosis (MS ... worsening and progression to higher scores of 3 and 4 on the EDSS scale. A subset of about 1,700 participants ...

Sacral neuromodulation, in which electrical pulses from an implanted device help control the bladder, was found to ease symptoms in MS.

Signs of neurological damage over time may not be needed for a diagnosis of MS in patients who strongly meet other criteria, ...

Marksans Pharma shares rose over 4% after its Goa plant secured Australian TGA approval for solid dosage forms. Its UK arm ...

Zim Laboratories said that the Portuguese drug regulator has granted approval for central nervous system (CNS) product Dimethyl Fumarate Modified Release Capsules to its European subsidiary SIA ZIM ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

These clumps, called stress granules, form in cells under duress ... the estimated total economic burden of multiple sclerosis in the U.S. was $85.4 billion in 2019, with a direct medical cost ...

"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as monotherapy in reducing disease activity in patients with ...

A NEW 4D brain map of marmosets with multiple sclerosis (MS)-like lesions has revealed potential early warning signs and therapeutic targets for the disease. Multiple sclerosis is a complex autoimmune ...